This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): Biosimilar Filgrastim (Hospira), Filgrastim Hospira (SC)
Description: Hospira's compound is a biosimilar of Amgen's approved drug, Neupogen (filgrastim).
Filgrastim Hospira News
Additional information available to subscribers only: